What an MDT Discussion Is Meant to Decide for Breast Cancer
A multidisciplinary team discussion brings together clinicians from different specialties to review one patient's case and agree on a recommended plan. For breast cancer, the specialties that matter most are usually breast surgery, medical oncology, radiation oncology, pathology and radiology. The point is not to collect opinions for their own sake. The point is to resolve questions that no single specialty can answer alone.
The discussion should produce a clear answer to a small number of practical questions. Which operation is appropriate for this tumour? Does the pathology and receptor information support surgery first, or another approach first? If breast-conserving surgery is possible, what will the cosmetic and follow-up consequences be? If mastectomy is recommended, is reconstruction part of the same plan or a separate discussion later? These are the questions an overseas patient should be able to trace through the written summary.
An MDT discussion is not a guarantee of any particular treatment. It is a review process. The treating hospital decides whether to hold one, who attends, and how its recommendation is recorded. Your job as a patient is to know what you need answered and to ask whether the hospital's process will address it.
Biopsy and Receptor Reports: The Questions That Change the Operation
The biopsy report and receptor status are not background paperwork. They directly shape what an MDT can recommend. The discussion should answer whether the receptor results are complete and whether any repeat or additional testing is needed before a surgical plan is fixed. If the receptor information is incomplete or conflicting, that is a specific question the MDT should resolve rather than leave open.
Ask what the receptor results mean for the sequence of treatment. Does the team recommend surgery first, or another treatment before surgery? If another treatment is recommended first, what is the reason, and how will the response be assessed? These are clinical decisions for the treating team, but the reasoning should be explained to you in terms you can follow.
The MDT should also answer whether the pathology has been reviewed by the hospital's own pathologist or whether the original slides and blocks need to be sent. A records-based review cannot confirm a diagnosis on its own. If the hospital wants its own pathology review, ask what material it needs, how long that step takes, and whether it changes the timing of any other part of the plan.
Previous Systemic Therapy: What the Team Needs to Know and Decide
If you have already received systemic therapy, the MDT discussion should answer how that treatment affects the surgical plan. The team needs a clear record of what was given, when, at what dose, and how the tumour responded. Without that record, the discussion is working from an incomplete picture, and the recommendation that comes out of it may not fit your actual situation.
The reason this matters is that previous treatment can change what the operation should be. A tumour that responded well to treatment given before surgery may be approached differently from one that did not respond, and a tumour that grew during treatment raises a different set of questions again. The MDT should state which of these situations applies to you and what it means for the recommended operation. Ask specifically whether the previous treatment changes the recommended operation, the timing of surgery, or the need for additional imaging before surgery. Ask whether any toxicity or side effect from previous treatment affects fitness for anaesthesia or recovery. These are questions for the treating clinicians, not decisions you should make from a guide.
There is also a practical records problem that overseas patients run into. Treatment given in another country is often documented in a different language, with different drug names and different reporting conventions. The MDT cannot weigh a treatment it cannot read. Ask the hospital what it needs: a translated summary, the original prescription records, infusion notes, or imaging from before and after the treatment. Ask whether the hospital wants its own pathologist to review the biopsy material alongside those records, and how long that step takes. If the hospital cannot say what it needs, that is itself a reason to clarify before you book travel.
The MDT should also answer what happens if the previous treatment was interrupted or incomplete. Does the team recommend completing it, changing it, or proceeding to surgery? This is a clinical judgement, but it should be a documented one. Ask who is responsible for that decision and when it will be made. If the answer is not clear in the written summary, ask for it to be clarified before you commit to travel, because the surgical plan may depend on it.
One more question is easy to overlook: what does the team need to know about side effects that are still active? If you are still experiencing fatigue, neuropathy, heart function changes or any other ongoing effect from previous treatment, that information belongs in the discussion. Ask whether those effects change the anaesthetic plan, the recovery plan, or the timing of surgery. The treating clinicians decide this, but they can only decide it if the information reaches them.
Finally, ask how the MDT's answer about previous therapy will be recorded. A verbal explanation during a consultation is useful, but a written summary that states the reasoning is easier to check later and easier to share with clinicians in your home country. If the hospital provides a written plan, ask whether it includes the previous treatment history and the team's conclusion about it. If it does not, ask for that to be added.
Surgical Extent and Reconstruction: Two Decisions, Not One
Breast-conserving surgery and mastectomy remove different amounts of breast tissue. That difference matters for the operation itself, for follow-up, and for how the breast looks afterwards. The MDT discussion should answer which operation is appropriate for your tumour and why, in terms you can understand.
Reconstruction is a separate discussion. It is not automatically part of the cancer operation, and it is not automatically available at every hospital. The MDT should answer whether reconstruction is being considered at the same time as the cancer surgery, later, or not at all, and who makes that decision. If reconstruction is discussed, ask which specialty would perform it and whether that clinician is part of the same team.
Ask what the recommended operation means for lymph nodes, for the need for radiotherapy afterwards, and for the follow-up schedule. These are clinical questions, but they should be answered before you decide where to have surgery. If the hospital cannot answer them clearly, that is useful information about whether it is the right place for your care.
What to Ask When the Hospital Does Not Offer a Formal MDT
Not every hospital holds a formal multidisciplinary meeting, and no hospital is obliged to provide one. If the hospital you are considering does not offer this format, that does not automatically mean the care is worse. It means you need to ask different questions to get the same clarity.
Ask who will coordinate your care across specialties. Ask whether the surgeon, medical oncologist and radiation oncologist communicate directly about your case, and how that communication is recorded. Ask whether you will receive a written plan that states the recommended operation, the reason for it, and the next steps.
If the hospital cannot describe how cross-specialty decisions are made, ask whether a records-based review by a relevant specialist is possible before you travel. A proxy consultation is optional and not a prerequisite for every appointment or operation. The free initial case review checks your available diagnosis, records and main question, identifies missing information and suggests the relevant next step. It is not a diagnosis or a promise of acceptance.
Preparing Your Records and Your Questions Before You Travel
The quality of any MDT discussion depends on the records available. Before you travel, gather your biopsy and receptor reports, pathology slides or blocks if they can be released, imaging reports and images, operative notes from any previous breast surgery, and a clear summary of systemic therapy already received. Ask the hospital what format it needs and whether translations are required.
Write down your questions in advance and bring them to the appointment. The most useful questions are specific: Which operation is recommended and why? Is reconstruction part of this plan or a separate decision? What does my previous treatment change? What is the next step, and who is responsible for it? Ask for the answers in writing if possible.
Keep the next step simple. Send a brief summary of your diagnosis, records and main question through the enquiry form, email or WhatsApp. The team will identify what is missing and suggest the relevant next step. You do not need to buy a proxy consultation to make an initial enquiry. The hospital decides suitability, and any treatment plan is confirmed only after the treating clinicians review your case.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.